Tussionex Pennkinetic Extended-release while Breastfeeding

What is Tussionex Pennkinetic Extended-release used for?

What are the risk associated with Tussionex Pennkinetic Extended-release usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Hydrocodone bitartrate while Breastfeeding

CAS Number: 125-29-1

Not commercially available in Spain

Chlorpheniramine maleate while Breastfeeding

CAS Number: 132-22-9

First generation antihistaminic and alchylamine drug, with sedative effect. Its active isomer is Dexchlorfeniramine. Likely inhibition of lactation within the first weeks post delivery because anti-prolactin effect.. Short-term and low dose (2 mg one or twice-day) treatment is compatible with breastfeeding. Be aware of somnolence in the child. For long-term treatment an alternative drug should be preferred. Compounds in association with expectorants, corticoids and cough relief medicines are available. Avoid drug associations especially while breastfeeding. Follow-up for sedation and feeding ability of the infant. Bed-sharing is not recommended for mothers who are taking this medication.

Hydrocodone bitartrate while Breastfeeding

CAS Number: 125-29-1

Hydrocodone is a opioid narcotic. Benzhydrocodone is a hydrocodone prodrug that is rapidly converted into hydrocodone in the gastrointestinal tract. Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system depression and even death. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of oral hydrocodone to a few days at a maximum dosage of 30 mg daily with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.

Chlorpheniramine maleate while Breastfeeding

CAS Number: 132-22-9

Small (2 to 4 mg), occasional doses of chlorpheniramine are acceptable during breastfeeding. Larger doses or more prolonged use might cause effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as spseudoephedrine or before lactation is well established. Single bedtime doses after the last feeding of the day may be adequate for many women and will minimize any effects of the drug. The nonsedating antihistamines are preferred alternatives, though.

What should I do if I am breastfeeding mother and I am already exposed to Tussionex Pennkinetic Extended-release?

I am nursing mother and my doctor has suggested me to use Tussionex Pennkinetic Extended-release, is it safe?

If I am using Tussionex Pennkinetic Extended-release, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Tussionex Pennkinetic Extended-release in breastfeeding?